What the Evidence Does Not Establish Stated as plainly as we can: It does not establish a safe or effective injectable dose of GHK-Cu in humans, for any endpoint, at any frequency, for any duration
Shashikanth, L
de Paiva IH, da Silva RS, Mendona IP, de Souza JR, Peixoto CA (2023) Semaglutide attenuates anxious and depressive-like behaviors and reverses the cognitive impairment in a type 2 diabetes mellitus mouse model via the microbiota-gut-brain axis
Antiplatelet therapy should not be discontinued
In those cases, the FDA requested manufacturers recall those drugs due to the impurities
When combining the two, expect nausea to be most pronounced during dose escalation periods, particularly when both compounds are being increased in close succession